IMVTImmunovant, Inc.

$30.48+106% 1Y

Is it safe?

Mixed

Nothing alarming, nothing pristine: insiders quiet and big price swings.

1 to watch, 1 neutral, 4 without data
Insider conviction-$856KSEC EDGAR · Oct 8, 2026

Insiders were net sellers (-$856K, 90 days to Oct 8, 2026), selling is often routine.

Drawdown risk57% volderived · Oct 9, 2026

Large price swings, high volatility. Worst drawdown -94% · now 32% below its 52-week high.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Volatilitybehind 74% of the market
Max drawdownbottom 7% of the market

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can IMVT take a bad year?

The deepest fall in IMVT's price history on file is −94%; it is 32% below its high today.

−94%

Worst drawdown on file · −32% today

Annualised volatility
57%

Annualised volatility · roughly twice as jumpy as the market

Details›
Cash and short-term investments
$798M
Annualised volatilitytwo years of daily moves
57%
Worst drawdown on file
−94%
Below its 52-week high
32%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.